Annual CFI
-$7.71B$5.94B-334.45%
Summary
- Current Value
- As of today, GSK annual cash from investing is -$7.71B, down -334.45% on
- Historical Performance
- GSK annual cash from investing is up +29.14% over the past 3 years, down -387.16% over the past 5 years
- All-Time High Comparison
- GSK annual cash from investing is currently -185.07% below its historical high of $9.06B set on
- 3-Year Low Comparison
- GSK annual cash from investing is +29.14% above its 3-year low of -$10.88B reached on an earlier date
- Sector Comparison
- GSK annual cash from investing is higher than 0.43% of companies in Healthcare sector
Cash From Investing Chart
Add series to chart1/6
Series
SUGGESTED SERIES
Performance
| Metric | Date | Value | 1Y | 3Y | 5Y | 15Y |
|---|---|---|---|---|---|---|
| Annual Cash From Investing | -$7.71B | -334.4% | +29.1% | -387.2% | -150.7% | |
| Quarterly Cash From Investing | -$3.18B | -110.9% | -726.8% | -7400.6% | -231.6% | |
| TTM Cash From Investing | -$7.74B | -331.9% | +28.3% | -388.5% | -151.6% | |
| Price | $60.85 | +66.5% | +69.6% | +73.3% | +52.4% | |
| Annual Cash From Operations | $9.62B | +23.7% | +17.9% | -1.9% | +1.4% | |
| Annual Cash From Financing | -$2.15B | +59.0% | -204.8% | +81.9% | +71.0% | |
| Annual CAPEX | $3.93B | +3.2% | +41.4% | +37.0% | +55.9% | |
| Annual Free Cash Flow | $5.69B | +43.2% | +5.8% | -17.9% | -18.3% | |
| Annual Total Assets | $82.21B | +10.4% | +13.6% | -25.2% | +24.3% |
Cash From Investing Highs
| Period | High | Date | Current |
|---|---|---|---|
| 3Y | -$1.77B | -334.4% | |
| 5Y | $2.69B | N/A | -387.2% |
| All | $9.06B | -185.1% |
Cash From Investing Lows
| Period | Low | Date | Current |
|---|---|---|---|
| 3Y | -$10.88B | N/A | +29.1% |
| 5Y | -$10.88B | +29.1% | |
| All | -$14.62B | +47.3% |
Cash From Investing History
FAQ
What is the current annual cash from investing of GSK?
As of today, GSK annual cash from investing is -$7.71B
What is 1-year change in GSK annual cash from investing?
GSK annual cash from investing is down -334.45% year-over-year
What is 3-year change in GSK annual cash from investing?
GSK annual cash from investing is up +29.14% over the past 3 years
How far is GSK annual cash from investing from its all-time high?
GSK annual cash from investing is currently -185.07% below its historical high of $9.06B set on December 31, 2015
How does GSK annual cash from investing rank versus sector peers?
GSK annual cash from investing is higher than 0.43% of companies in Healthcare sector
When is GSK next annual earnings release?
As of today, the next annual earnings release for GSK has not been scheduled
Quarterly CFI
-$3.18B$1.03B-47.90%
Summary
- Current Value
- As of today, GSK quarterly cash from investing is -$3.18B, down -47.90% on
- Historical Performance
- GSK quarterly cash from investing is down -110.91% year-over-year, down -726.83% over the past 3 years
- All-Time High Comparison
- GSK quarterly cash from investing is currently -129.85% below its historical high of $10.66B set on
- 3-Year Low Comparison
- GSK quarterly cash from investing is at its 3-year low
- Sector Comparison
- GSK quarterly cash from investing is higher than 0.28% of companies in Healthcare sector
Performance
| Metric | Date | Value | 3M | 1Y | 3Y | 5Y |
|---|---|---|---|---|---|---|
| Quarterly Cash From Investing | -$3.18B | -47.9% | -110.9% | -726.8% | -7400.6% | |
| Annual Cash From Investing | -$7.71B | – | -334.4% | +29.1% | -387.2% | |
| TTM Cash From Investing | -$7.74B | -27.6% | -331.9% | +28.3% | -388.5% | |
| Price | $60.85 | +31.3% | +66.5% | +69.6% | +73.3% | |
| Quarterly Cash From Operations | $2.74B | -9.5% | -3.2% | +56.8% | -40.7% | |
| Quarterly Cash From Financing | $1.09B | +163.8% | +228.9% | +183.1% | +143.1% | |
| Quarterly CAPEX | $1.35B | +11.9% | -10.4% | +56.2% | +20.6% | |
| Quarterly Free Cash Flow | $1.40B | -23.6% | +5.0% | +57.4% | -60.2% | |
| Quarterly Total Assets | $82.21B | -0.5% | +10.4% | +13.6% | -25.2% |
Quarterly Cash From Investing Highs
| Period | High | Date | Current |
|---|---|---|---|
| 1Y | -$823.69M | -286.5% | |
| 3Y | $924.65M | -444.3% | |
| 5Y | $924.65M | -444.3% | |
| All | $10.66B | -129.8% |
Quarterly Cash From Investing Lows
| Period | Low | Date | Current |
|---|---|---|---|
| 1Y | -$3.18B | at low | |
| 3Y | -$3.18B | at low | |
| 5Y | -$5.00B | +36.4% | |
| All | -$13.29B | +76.0% |
Quarterly Cash From Investing History
FAQ
What is the current quarterly cash from investing of GSK?
As of today, GSK quarterly cash from investing is -$3.18B
What is GSK quarterly cash from investing most recent change?
GSK quarterly cash from investing was down -47.90% on December 31, 2025
What is 1-year change in GSK quarterly cash from investing?
GSK quarterly cash from investing is down -110.91% year-over-year
How far is GSK quarterly cash from investing from its all-time high?
GSK quarterly cash from investing is currently -129.85% below its historical high of $10.66B set on March 31, 2015
How does GSK quarterly cash from investing rank versus sector peers?
GSK quarterly cash from investing is higher than 0.28% of companies in Healthcare sector
When is GSK next earnings release?
The next earnings release for GSK is on
TTM CFI
-$7.74B$1.67B-27.60%
Summary
- Current Value
- As of today, GSK TTM cash from investing is -$7.74B, down -27.60% on
- Historical Performance
- GSK TTM cash from investing is down -331.87% year-over-year, up +28.27% over the past 3 years
- All-Time High Comparison
- GSK TTM cash from investing is currently -182.96% below its historical high of $9.33B set on
- 3-Year Low Comparison
- GSK TTM cash from investing is +28.27% above its 3-year low of -$10.79B reached on an earlier date
- Sector Comparison
- GSK TTM cash from investing is higher than 0.46% of companies in Healthcare sector
Performance
| Metric | Date | Value | 3M | 1Y | 3Y | 5Y |
|---|---|---|---|---|---|---|
| TTM Cash From Investing | -$7.74B | -27.6% | -331.9% | +28.3% | -388.5% | |
| Annual Cash From Investing | -$7.71B | – | -334.4% | +29.1% | -387.2% | |
| Quarterly Cash From Investing | -$3.18B | -47.9% | -110.9% | -726.8% | -7400.6% | |
| Price | $60.85 | +31.3% | +66.5% | +69.6% | +73.3% | |
| TTM Cash From Operations | $9.66B | -0.9% | +22.9% | +19.4% | -1.4% | |
| TTM Cash From Financing | -$2.15B | +47.3% | +59.3% | -206.4% | +81.9% | |
| TTM CAPEX | $3.95B | -3.8% | +2.6% | +43.2% | +37.6% | |
| TTM Free Cash Flow | $5.71B | +1.2% | +42.4% | +7.1% | -17.6% | |
| Quarterly Total Assets | $82.21B | -0.5% | +10.4% | +13.6% | -25.2% |
TTM Cash From Investing Highs
| Period | High | Date | Current |
|---|---|---|---|
| 1Y | -$1.79B | N/A | -331.9% |
| 3Y | $292.30M | -2748.0% | |
| 5Y | $2.73B | -383.8% | |
| All | $9.33B | -183.0% |
TTM Cash From Investing Lows
| Period | Low | Date | Current |
|---|---|---|---|
| 1Y | -$7.74B | at low | |
| 3Y | -$10.79B | N/A | +28.3% |
| 5Y | -$10.88B | +28.9% | |
| All | -$19.30B | +59.9% |
TTM Cash From Investing History
FAQ
What is the current TTM cash from investing of GSK?
As of today, GSK TTM cash from investing is -$7.74B
What is GSK TTM cash from investing most recent change?
GSK TTM cash from investing was down -27.60% on December 31, 2025
What is 1-year change in GSK TTM cash from investing?
GSK TTM cash from investing is down -331.87% year-over-year
How far is GSK TTM cash from investing from its all-time high?
GSK TTM cash from investing is currently -182.96% below its historical high of $9.33B set on March 31, 2015
How does GSK TTM cash from investing rank versus sector peers?
GSK TTM cash from investing is higher than 0.46% of companies in Healthcare sector
When is GSK next earnings release?
The next earnings release for GSK is on
Cash From Investing Formula
CFI = Cash Inflows from Investments − Cash Outflows for Investments
Data Sources & References
- GSK Official Website www.gsk.com
- Most Recent Quarterly Report (10-Q) www.sec.gov/Archives/edgar/data/1131399/000165495426000892/0001654954-26-000892-index.htm
- GSK Profile on Yahoo Finance finance.yahoo.com/quote/GSK
- GSK Profile on NASDAQ.com www.nasdaq.com/market-activity/stocks/gsk